Alpha Tau Medical (NASDAQ:DRTS) & Envoy Medical (NASDAQ:COCH) Head to Head Analysis

Alpha Tau Medical (NASDAQ:DRTS) and Envoy Medical (NASDAQ:COCH) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their earnings, risk, analyst recommendations, profitability, institutional ownership, dividends and valuation.

Earnings and Valuation

This table compares Alpha Tau Medical and Envoy Medical”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alpha Tau Medical	N/A	N/A	-$42.63 million	($0.67)	-17.75
Envoy Medical	$234,000.00	218.98	-$23.76 million	($1.01)	-0.66

Envoy Medical has higher revenue and earnings than Alpha Tau Medical. Alpha Tau Medical is trading at a lower price-to-earnings ratio than Envoy Medical, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Alpha Tau Medical and Envoy Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Alpha Tau Medical	N/A	-73.23%	-52.90%
Envoy Medical	-9,875.64%	N/A	-177.92%

Analyst Ratings

This is a breakdown of recent ratings and price targets for Alpha Tau Medical and Envoy Medical, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alpha Tau Medical	2	1	5	0	2.38
Envoy Medical	1	1	1	0	2.00

Alpha Tau Medical presently has a consensus target price of $12.60, indicating a potential upside of 5.97%. Envoy Medical has a consensus target price of $2.25, indicating a potential upside of 237.58%. Given Envoy Medical’s higher probable upside, analysts plainly believe Envoy Medical is more favorable than Alpha Tau Medical.

Institutional and Insider Ownership

2.6% of Alpha Tau Medical shares are held by institutional investors. Comparatively, 8.6% of Envoy Medical shares are held by institutional investors. 39.5% of Alpha Tau Medical shares are held by company insiders. Comparatively, 7.1% of Envoy Medical shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Risk & Volatility

Alpha Tau Medical has a beta of 1.17, meaning that its share price is 17% more volatile than the S&P 500. Comparatively, Envoy Medical has a beta of 1.88, meaning that its share price is 88% more volatile than the S&P 500.

Summary

Envoy Medical beats Alpha Tau Medical on 7 of the 13 factors compared between the two stocks.

About Alpha Tau Medical

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, prostate, and breast cancers; and preclinical studies for brain, hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. The company was incorporated in 2015 and is headquartered in Jerusalem, Israel.

About Envoy Medical

Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.